TickerFacts.

Chemomab Therapeutics Ltd. (CMMB): EPS (Basic)

Annual figures by period end, from SEC filings.

$0.018
Year ended 2025-12-31
-47.0%
3-year compound annual growth
$0.122021-12-31: $0.062022-12-31: $0.122023-12-31: $0.102024-12-31: $0.0392025-12-31: $0.018$0.018
2021-12-31 EPS (Basic) (USD per share) 2025-12-31
Period endedEPS (Basic)Change YoYSource filing
2025-12-31$0.018-53.8%2026-03-23, From 2025-01-01
2024-12-31$0.039-62.1%2026-03-23, From 2024-01-01
2023-12-31$0.10-14.9%2026-03-23, From 2023-01-01
2022-12-31$0.12+101.7%2025-04-04, From 2022-01-01
2021-12-31$0.06n/a2024-03-28, From 2021-01-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Basic)Change YoY
Chemomab Therapeutics Ltd. (CMMB)2025-12-31$0.018-53.8%
CytoDyn Inc. (CYDY)2026-05-31-$0.03n/a
Actuate Therapeutics, Inc. (ACTU)2025-12-31-$1.06n/m
CalciMedica, Inc. (CALC)2025-12-31-$1.97n/m
Exicure, Inc. (XCUR)2025-12-31-$0.79n/m
Edesa Biotech, Inc. (EDSA)2025-09-30-$1.27n/m
Biovie Inc. (BIVI)2026-06-30-$3.05n/m
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31-$1.34n/m
Cellectar Biosciences, Inc. (CLRB)2025-12-31-$8.35n/m

Compare CMMB, CYDY, ACTU, CALC side by side · Screen every company in Pharmaceutical Preparations ↗